CONGRESSES

Our medical oncologists and laboratory investigators are regular speakers and organizers of some of the most important international seminars and scientific meetings.

We have presented the results of our investigations into the causes of cancer and novel treatments at some of the most important national and international oncology congresses.

BROWSE CONGRESSES
BY YEAR

II Reunión Traslacional en Melanoma

DATE03/11/2016

PLACEBarcelona, Spain

Predictive biomarkers for immune resistance and combinatory therapies with anti-PD-1 and anti-PD-L1 antibodies Rafael Rosell, MD, PhD

cfDNA multiplex analysis platform Miguel Angel Molina, PhD

RNA expression analysis: different sources and techniques Dr. Niki Karachaliou, PhD

HIV and cancer: anti-PD-1 treatment Dr. María González-Cao

Jornada Canaria de Cáncer de Pulmón Metastásico

DATE14/10/2016

PLACEGran Canaria, Spain

Cáncer de Pulmón ALK Positivo Dr. Santiago Viteri

Annual Congress, European Society of Medical Oncology (ESMO)

DATE07/10/2016 - 11/10/2016

PLACECopenhagen, Denmark

Poly-therapy with EGFR, STAT3 and Src-YAP1 signaling pathway inhibition; A breakthrough for EGFR mutant NSCLC N. Karachaliou, I. Chaib, X. Cai, X. Li, A.F. Cardona, G. López-Vivanco, A. Vergnenegre, J.M. Sanchez Torres, M. Provencio, F. de Marinis, E. Carecereny, N. Reguart, R. García Campelo, S. Viteri, M.A. Molina Vila, C. Zhou, P. Cao, P.Ma, T. Bivona, R. Rosell Poster 1188P

[return]
Brigatinib (BRG) in patients (Pts) with anaplastic lymphoma kinase (ALK)–positive non–small cell lung cancer (NSCLC) in a phase 1/2 trial
L. Bazhenova, S. Gettinger, C. Langer, R. Salgia, K. Gold, R. Rosell, A. Shaw, G. Weiss, J. Haney, V. Rivera, F. Haluska, D. Kerstein, D. R. Camidge Poster 1207PD

Molecular analysis in serial biopsies in sinonasal mucosal melanoma
G. Anguera Palacios, M.Á. Molina-Vila, J.R. Gras-Cabrerizo, X. León, C. Mayo, J. Codony Servat, A. Pérez-Rosado, S. Rodríguez, M. González-Cao, N. Karachaliou, A. Barnadas, R. Rosell, M. Majem Poster 1005P

Automated nCounter-based assay for identifying clinically relevant ALK, ROS1 and RET rearrangements in advancednon-small cell lung cancer (NSCLC)
N. Reguart, L. Paré, A. Giménez-Capitán, C. Teixidó, P. Galván, S. Viteri, S. Rodríguez, V. Peg, E. Aldeguer, E. Ovalle, N. Viñolas, S. Merkelbach-Bruse, F. Lopez-Rios, R. Rosell, M.Á. Molina-Vila, A. Prat

The development of a narrow target gene panel makes next generation sequencing effective for circulating free DNA analysis
U. Malapelle, C. Mayo, D. Rocco, M. Garzon, P. Pisapia, R. Sgariglia, C. De Luca, N.J. Ariza, F. Pepe, D.M. Espinosa, A.M. Bueno, M. González-Cao, N. Karachaliou, S. Viteri, M.A. Molina Vila, R. Rosell, G. Troncone Poster 66P

Biomarker driven combinations for synthetic lethal approaches in KRAS mutant (KRASm) lung adenocarcinoma (LAC)
C. Lazzari, A. Verlicchi, C. Codony Servat, J. Codony Servat, M.A. Molina Vila, I. Chaib, J.L. Ramírez Serrano, N. Karachaliou, F. de Marinis, R. Rosell Poster 1526P

Differential expression profile of lung squamous cell carcinoma (LSCC) and druggable targets to be combined with necitumumab (N)
A. Verlicchi, C. Lazzari, C. Codony Servat, M.A. Molina Vila, J. Codony Servat, I. Chaib, J.L. Ramírez Serrano, N. Karachaliou, C. Dazzi, R. Rosell Poster 1527P

I International Workshop on Genomic Testing in Cancer

DATE28/09/2016 - 30/09/2016

PLACE Clínica Universitaria de Navarra, Pamplona, Spain

Genomic Testing as a Key Tool in Precision Medicine Rosell R.

1st International Molecular Diagnostics Congress

DATE14/09/2016 - 15/09/2016

PLACEBarcelona, Spain

Unlocking Personalized Medicine through companion diagnostics. Organized by Genetic Insider

Utility of liquid biopsies in the treatment of oncologic patients Clara Mayo, PhD, Director, Liquid Biopsy Research Program, Panagea Biotech

REGISTER